These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19223852)

  • 1. Clinical application of NKT cell biology in type I (autoimmune) diabetes mellitus.
    Fletcher MT; Baxter AG
    Immunol Cell Biol; 2009; 87(4):315-23. PubMed ID: 19223852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
    Cardell SL
    Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes.
    Kadri N; Korpos E; Gupta S; Briet C; Löfbom L; Yagita H; Lehuen A; Boitard C; Holmberg D; Sorokin L; Cardell SL
    J Immunol; 2012 Apr; 188(7):3138-49. PubMed ID: 22371394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preventive role of type 2 NKT cells in the development of type 1 diabetes.
    Sørensen JØ; Buschard K; Brogren CH
    APMIS; 2014 Mar; 122(3):167-82. PubMed ID: 23992281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1d-restricted NKT regulatory cells: functional genomic analyses provide new insights into the mechanisms of protection against Type 1 diabetes.
    Mi QS; Meagher C; Delovitch TL
    Novartis Found Symp; 2003; 252():146-60; discussion 160-4, 203-10. PubMed ID: 14609217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8(+)NKT-like cells regulate the immune response by killing antigen-bearing DCs.
    Wang C; Liu X; Li Z; Chai Y; Jiang Y; Wang Q; Ji Y; Zhu Z; Wan Y; Yuan Z; Chang Z; Zhang M
    Sci Rep; 2015 Sep; 5():14124. PubMed ID: 26369936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of immune responses by natural killer T cells.
    Sharif S; Delovitch TL
    Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 1():S23-31. PubMed ID: 11603866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKT and tolerance.
    Diana J; Beaudoin L; Gautron AS; Lehuen A
    Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular mechanisms of CCL22-mediated attenuation of autoimmune diabetes.
    Bischoff L; Alvarez S; Dai DL; Soukhatcheva G; Orban PC; Verchere CB
    J Immunol; 2015 Apr; 194(7):3054-64. PubMed ID: 25740943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes.
    Beaudoin L; Diana J; Ghazarian L; Simoni Y; Boitard C; Lehuen A
    Eur J Immunol; 2014 May; 44(5):1454-66. PubMed ID: 24481989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic control of NKT cell numbers maps to major diabetes and lupus loci.
    Esteban LM; Tsoutsman T; Jordan MA; Roach D; Poulton LD; Brooks A; Naidenko OV; Sidobre S; Godfrey DI; Baxter AG
    J Immunol; 2003 Sep; 171(6):2873-8. PubMed ID: 12960309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of type 1 diabetes by NKT cells.
    Novak J; Griseri T; Beaudoin L; Lehuen A
    Int Rev Immunol; 2007; 26(1-2):49-72. PubMed ID: 17454264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the NKT cell hypothesis of human IDDM pathogenesis.
    Lee PT; Putnam A; Benlagha K; Teyton L; Gottlieb PA; Bendelac A
    J Clin Invest; 2002 Sep; 110(6):793-800. PubMed ID: 12235110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functions of type I and type II natural killer T cells in inflammatory bowel diseases.
    Liao CM; Zimmer MI; Wang CR
    Inflamm Bowel Dis; 2013 May; 19(6):1330-8. PubMed ID: 23518808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
    Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer T cells: drivers or passengers in preventing human disease?
    Berzins SP; Ritchie DS
    Nat Rev Immunol; 2014 Sep; 14(9):640-6. PubMed ID: 25103356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-13 Pathway Alterations Impair Invariant Natural Killer T-Cell-Mediated Regulation of Effector T Cells in Type 1 Diabetes.
    Usero L; Sánchez A; Pizarro E; Xufré C; Martí M; Jaraquemada D; Roura-Mir C
    Diabetes; 2016 Aug; 65(8):2356-66. PubMed ID: 27207542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of natural killer T (NKT) cells in the pathogenesis of type 1 diabetes.
    Gómez-Díaz RA; Aguilar MV; Meguro EN; Márquez RH; Magaña EG; Martinez-García MC; Rodarte NW; Aguilar-Salinas CA; Canché-Pool E; Ortiz-Navarrete V
    Curr Diabetes Rev; 2011 Jul; 7(4):278-83. PubMed ID: 21644914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.
    Webb TJ; Carey GB; East JE; Sun W; Bollino DR; Kimball AS; Brutkiewicz RR
    Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27297969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.